XDive

XDive

The XDive® 5 Superfast Real-Time PCR Machine is a next-generation qPCR platform designed for ultra-rapid nucleic acid amplification, co-developed with pioneers of ultrafast PCR. Capable of completing a 40-cycle qPCR in just 5 minutes with performance on par with conventional instruments, XDive supports up to 16 reactions simultaneously with quadruplex multiplexing and panel detection of 64 targets.

When integrated with Xtractor™ and Xprep™, it enables a fully automated, sample-to-answer workflow in under 15 minutes, making it ideal for clinical diagnostics, infectious disease testing, and high-throughput molecular labs.

With TÜV certifications, ISO 13485 compliance, and FDA EUA-authorized reagent kits, the XDive is positioned as one of the fastest, most reliable PCR systems available for research and clinical applications.

For More Info: Download Datasheet

Key Bullet Points

  • Co-developed with Prof. Carl Wittwer (BioFire co-founder, pioneer of ultrafast PCR).

  • Ultra-fast performance:

    • 40-cycle qPCR in ~5 minutes.

    • RT-qPCR in ~7 minutes.

  • Throughput: 1–16 reaction wells per run, 5–30 μL per reaction.

  • Multiplexing: Up to 4 targets per tube (expandable to 6); panel detection of up to 64 targets in one run.

  • Fluorescence channels: Standard FAM, HEX, ROX, Cy5 (expandable to 6 channels).

  • Sensitivity & precision: Detects as low as ~30 copies/ml; excellent uniformity and reproducibility across wells.

  • Sample-to-result workflow:

    • With Xtractor™ nucleic acid extractor + Xprep™ reagent prep module → fully automated results in <15 minutes.

  • Thermal cycling: Translational tube movement among heating baths for ultrafast ramp rates.

    • Ramp up: 82°C/s (outside tube), 285°C/s (inside).

    • Ramp down: 67°C/s (outside tube), 17.5°C/s (inside).

    • Uniformity: ±0.5°C.

  • Compact footprint: 450×342×357 mm; weight 24.5 kg.

  • Certified:

    • TÜV-certified (IEC 61010, IEC 61326-2-6:2020).

    • Manufacturing under ISO 13485.

  • Regulatory/EUA: FDA EUA for COVID-19 RT-qPCR, SalivaDirect™, and Monkeypox kits.

Patents granted: U.S., China, EU, Japan, Australia, India, Singapore.